In a double-blind, randomized and placebo-controlled trial, adjuvant memantine improved symptoms in inpatients suffering from refractory obsessive-compulsive disorders (OCD) - Haghighi, M; Jahangard, L; Mohammad-Beigi, H (Psychopharmacology (Berl), 2013)
et al.